SHANGHAI PUDONG--(BUSINESS WIRE)--The Chinese pharmaceutical industry is accelerating its expansion into major global markets, not only in its traditional area of strength, the manufacture of pharmaceutical raw materials (APIs), but particularly in finished formulations such as tablets, capsules and injections. These are areas of the market for off patent (or generic) medicines, which have traditionally been dominated by Indian companies. For that reason, the China Centre for Pharmaceutical International Exchange (CCPIE) of the Chinese State Food and Drug Administration (SFDA), is holding its second International Forum on Generic Drugs in Shanghai today and tomorrow.
